Skip to content
Medical Health Aged Care

Dementia Australia supports Ballina and Casino

Dementia Australia 3 mins read

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Ballina and Casino between 4 and 8 March.

It is estimated there are more than 141,000 people living with dementia in New South Wales. Without a medical breakthrough this number is expected to increase to more than 252,000 people living with dementia by 2054.

These Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential.


Carer Wellness Program

This group session is designed to support positive health and wellbeing outcomes for a carer, family or friend of a person living with dementia.

  • Monday 4 March 9:30am-3pm in Lismore

 

Understanding Dementia

This session provides and introduction to dementia including an overview of different types of dementia, diagnosis, planning ahead and how to support someone living with dementia.

  • Tuesday 5 March 9:30am-12pm in Ballina

 

It Starts With You

If you are passionate about your local community and want to make it more dementia-friendly, then this session is for you.

  • Tuesday 5 March 1pm-1:30pm in Ballina

 

Consumer Engagement Information Session

This session will provide an overview of the three flagship Consumer Engagement programs available at Dementia Australia: Dementia Advocates, Connection Peers and Dementia-Friendly Communities.

  • Tuesday 5 March 1:30pm-2:30pm in Ballina

 

Considering Residential Care

This session provides information about the process of considering and preparing for residential care.

  • Tuesday 5 March 2:45pm-5pm in Ballina

 

Driving With Dementia

This program provides information about the impact of dementia on driving. It offers tips for recognising when dementia is impacting on someone’s ability to drive safely, the importance of planning ahead, and acknowledging the significance of retiring from driving.

  • Wednesday 6 March 9:30am-12pm in Ballina

 

Activities At Home

This practical session assists carers looking after someone at home to plan engaging activities. It promotes independence and wellbeing by focusing on what the person with dementia can still do.

  • Wednesday 6 March 1pm-2:45pm in Ballina

 

Communication and Dementia

The session provides information on dementia, the way we communicate and how changes in communication can occur as a result of dementia.

  • Wednesday 6 March 3pm-5:30pm in Ballina

 

Understanding Changes in Behaviour

This session provides an introduction to dementia and changes to the brain, effects on behaviour and the impacts of changed behaviour. It will introduce problem solving models, including strategies to minimise and respond to changed behaviour.

  • Thursday 7 March 9:30am-12:30pm in Ballina and Friday 8 March 1:30pm-3:30pm in Casino

 

EDIE for Family Carers

This session enhances knowledge of dementia through virtual reality technology that allows participants to see the world through the eyes of a person living with dementia.

  • Thursday 7 March 1:30pm-4:30pm in Ballina and Friday 8 March 9:30am-12:30pm in Casino

 

Bookings are essential. Visit https://www.dementia.org.au/brainhub/ballina-casino for details and to register. You can also call the National Dementia Helpline to register for this course on 1800 100 500. The National Dementia Helpline is available 24 hours a day, seven days a week.

 

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 400,000 Australians living with dementia, and the more than 1.5 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

-Ends-

Media contacts: Stephen O’Connell, Media & Communications Advisor, Stephen.oconnell@dementia.org.au, 0402 284 257

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

 

Media

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.